Ignite Creation Date:
2025-12-24 @ 3:48 PM
Ignite Modification Date:
2026-01-02 @ 12:48 PM
Study NCT ID:
NCT01852292
Status:
TERMINATED
Last Update Posted:
2018-07-24
First Post:
2013-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-03-30
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-08
First Submit QC Date:
None
Study First Post Date:
2013-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-03-30
Results First Submit QC Date:
None
Results First Post Date:
2018-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-06-26
Last Update Post Date:
2018-07-24
Last Update Post Date Type:
ACTUAL